Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule (Q51026982)
Jump to navigation
Jump to search
scientific article published on 19 February 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule |
scientific article published on 19 February 2004 |
Statements
Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule (English)
1 reference
Giovanni Martinelli
1 reference
Michele Ghielmini
1 reference
Shu-Fang Hsu Schmitz
1 reference
Sergio B Cogliatti
1 reference
Gabriella Pichert
1 reference
Jörg Hummerjohann
1 reference
Ursula Waltzer
1 reference
Martin F Fey
1 reference
Daniel C Betticher
1 reference
Fedro Peccatori
1 reference
Urs Hess
1 reference
Emanuele Zucca
1 reference
Roger Stupp
1 reference
Tibor Kovacsovics
1 reference
Claudine Helg
1 reference
Andreas Lohri
1 reference
Mario Bargetzi
1 reference
Daniel Vorobiof
1 reference
Thomas Cerny
1 reference
19 February 2004
1 reference
1 reference
103
1 reference
12
1 reference
4416-4423
1 reference
Identifiers
1 reference